Bioxodes

Gosselies, Belgium · Founded 2010 · Privately Held (backing)

Operator of a clinical-stage biopharmaceutical company intended to prevent and treat thrombotic and inflammatory diseases. Bioxodes is based in Gosselies, Belgium and was founded in 2010. Its last reported valuation was $116 million in Feb 2025. It has raised $39.1 million.

Last reported valuation
$115.5M
Oct 2026
Priced at
—
Total raised
$39.1M
Last round
—

Who backs Bioxodes?

12 investors
InvestorType
European Regional Development Fund (Brandenburg)Other
SambrInvestOther
Société Fédérale de Participations et d'InvestissementOther
Federal Holding and Investment Company (Brussels)Other
Université Libre de BruxellesOther
Investsud—
Jean Stéphenne—
Life Sciences Research Partners—
Newton BioCapital—
Olivier van der Rest—
+ 2 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Bioxodes investors

Free account
More of Bioxodes with a free account
  • ·The complete investor list: 12 names
  • ·Watch Bioxodes: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 12 firms already write checks for companies like Bioxodes. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View